Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HAGH |
| Upstream (Parents) |
|---|
| (<<) HMGCL → HAGH |
| (<<) PXMP2 → HAGH |
| Downstream (Children) |
|---|
| HAGH → SEPX1 (>>) |
| HAGH → ACBD4 (>>) |
| HAGH → DNMT3L (>>) |
| HAGH → STAB2 (>>) |
| HAGH → RHEB (>>) |
| HAGH → JMJD5 (>>) |
| HAGH → SFRP5 (>>) |
| HAGH → SERPINA2 (>>) |
| HAGH → OXT (>>) |
| HAGH → FGGY (>>) |
| HAGH → ADI1 (>>) |
| HAGH → CRYL1 (>>) |
| HAGH → AMT (>>) |
